T6	Subject 0 35	Two patients with adrenal carcinoma
T8	Treatment 49 138	2,2-bis (2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane (o,p'-DDD) as adjuvant therapy
T9	Population 0 3	Two
T11	Drug 49 107	2,2-bis (2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane
T12	Treat-Disorder 18 35	adrenal carcinoma
T7	Potential_therapeutic_event 36 43	treated
E1	Potential_therapeutic_event:T7 
